Value: The Next Frontier in Cancer Care

Value: The Next Frontier in Cancer Care

Value has become a central topic in any debate regarding cancer care in the U.S. and abroad, for a simple reason: reality has caught up with us. Costs and treatment innovations are conflicting realities that force the oncology community to adopt value-based solutions to a system in crisis [1]. Although the oncology landscape is complex, we can try to depict the cancer crisis as the clash of con...

Long term care: the next healthcare frontier.

Point-of-care devices: the next frontier in personalized chemotherapy

The ‘standard-of-care’ is the commonest type of treatment, determined by averaging responses across large cohorts. However, every patient has their own genetic background and lifestyle, which indicates that each one should receive individualized care as based on clinical trials. The ‘Precise Medicine’ era has emerged to achieve successful treatment for each patient based on their personal chara...

Cancer Immunoprevention Series Cancer Immunoprevention—The Next Frontier

Cancer immunotherapy is a rapidly developing field, but limited in its success by a high tumor burden and immune tolerance. In contrast, immunoprevention has the potential to prevent cancer before the development of immune tolerance, and to prevent cancer recurrence in the setting of minimal residual disease. Although immunoprevention for viral-induced cancers has been successful in the setting...

Reliability: the next frontier

The goal of my graduate research has been finding architectural solutions to key technological challenges facing processor design that impact reliability, power, and performance of multicores. The rapidly shrinking feature sizes provided by the Moore’s Law with each successive technology generation make the devices on a chip increasingly susceptible to soft errors, hard errors, process variatio...